Clinical outcomes of medical treatments for progressive desmoid tumors following active surveillance: A systematic review
Not Applicable
- Conditions
- desmoid tumor
- Registration Number
- JPRN-UMIN000042788
- Lead Sponsor
- Department of Orthopaedic Surgery, Nara Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 24
Inclusion Criteria
Not provided
Exclusion Criteria
We excluded studies with unclear indication of outcomes, review articles, isolated case reports or case series including fewer than five patients, non-English abstracts, and conference abstracts. We excluded studies that did not specify progressive disease as the inclusion criterion or those that reported effectiveness and toxicity of antihormonal therapies or NSAIDs.
Study & Design
- Study Type
- Others,meta-analysis etc
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Progression-free survival, reduction of tumor size by the modified Response Evaluation Criteria in Solid Tumors (RECIST; version 1.1), disease control rate, and adverse events evaluated by Common Terminology Criteria for Adverse Events (CTCAE; version 5.0).
- Secondary Outcome Measures
Name Time Method